Product Name : | CJC-1295/Ipamorelin | ||
Cas No. : | 446262-90-4 | State : | |
Molecular Formula : | Purity/Specification : | 99% | |
Boiling Point : | Storage : | Minimize open air exposure, store in a cool dry place,Keep this product out of the reach of children. |
The right place to buy CJC-1295/Ipamorelin peptide raw powder as research chemical with lab-test quality, well packing and shipping from china to worldwide. Each batch may be tested in vials by institutions appointed by our clients,janoshik.com for example , in that the quality is guaranteed.
Keep in mind that updates on pharmaceuticals may occure any time , and it is advisable that the information provided here should not be relied upon or used as the sole basis for making decisions without consulting primary, more accurate, more complete or more timely sources of information.
Please refer to our Terms of Service prior to buy CJC-1295/Ipamorelin peptide raw powder either in vials or bags.Please be noted that this product is sold as a pure compound for research purposes only and is NOT meant for use as a dietary supplement.
Introduction:
CJC-1295 is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) class. It has garnered attention for its potential role in stimulating the release of growth hormone and insulin-like growth factor 1 (IGF-1). While primarily explored for its applications in stimulating growth hormone secretion, CJC-1295 is also being investigated for its potential benefits in various areas, including body composition, muscle growth, and anti-aging.In the realm of peptide-based therapeutics, CJC-1295 has emerged as a promising compound with the ability to influence the body’s production of growth hormone. Its development stems from the desire to enhance the benefits associated with growth hormone, such as improved muscle mass, reduced body fat, and potential anti-aging effects.
CJC-1295 is an analog of GHRH and works by binding to the growth hormone-releasing hormone receptor. This interaction stimulates the pituitary gland to release increased amounts of growth hormone into the bloodstream. The extended half-life of CJC-1295, due to its modification with a drug-binding protein (DAC – Drug Affinity Complex), allows for a sustained and more stable release of growth hormone compared to the natural GHRH.
CJC-1295 stands at the forefront of peptide research, showcasing potential in the modulation of growth hormone release and its associated benefits. As the field of peptide therapeutics continues to advance, CJC-1295 holds promise for further exploration in various areas of medicine, including endocrinology, sports science, and anti-aging interventions. Always consult with healthcare professionals before considering the use of CJC-1295 or any peptide-based therapy.